478 related articles for article (PubMed ID: 30678043)
21. Role of Ceramide in Apoptosis and Development of Insulin Resistance.
Kuzmenko DI; Klimentyeva TK
Biochemistry (Mosc); 2016 Sep; 81(9):913-27. PubMed ID: 27682164
[TBL] [Abstract][Full Text] [Related]
22. Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.
Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD
Diabetes; 2017 Aug; 66(8):2082-2091. PubMed ID: 28483801
[TBL] [Abstract][Full Text] [Related]
23. Role of skeletal muscle lipids in the pathogenesis of insulin resistance of obesity and type 2 diabetes.
Gilbert M
J Diabetes Investig; 2021 Nov; 12(11):1934-1941. PubMed ID: 34132491
[TBL] [Abstract][Full Text] [Related]
24. Oleate dose-dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes.
Capel F; Cheraiti N; Acquaviva C; Hénique C; Bertrand-Michel J; Vianey-Saban C; Prip-Buus C; Morio B
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2000-2010. PubMed ID: 27725263
[TBL] [Abstract][Full Text] [Related]
25. Ceramides and glucosylceramides are independent antagonists of insulin signaling.
Chavez JA; Siddique MM; Wang ST; Ching J; Shayman JA; Summers SA
J Biol Chem; 2014 Jan; 289(2):723-34. PubMed ID: 24214972
[TBL] [Abstract][Full Text] [Related]
26. Temporal changes in sphingolipids and systemic insulin sensitivity during the transition from gestation to lactation.
Rico JE; Saed Samii S; Mathews AT; Lovett J; Haughey NJ; McFadden JW
PLoS One; 2017; 12(5):e0176787. PubMed ID: 28486481
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content.
Coen PM; Dubé JJ; Amati F; Stefanovic-Racic M; Ferrell RE; Toledo FG; Goodpaster BH
Diabetes; 2010 Jan; 59(1):80-8. PubMed ID: 19833891
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine 1-phosphate metabolism and insulin signaling.
Wigger D; Schumacher F; Schneider-Schaulies S; Kleuser B
Cell Signal; 2021 Jun; 82():109959. PubMed ID: 33631318
[TBL] [Abstract][Full Text] [Related]
30. Ceramide Transporter CERT Is Involved in Muscle Insulin Signaling Defects Under Lipotoxic Conditions.
Bandet CL; Mahfouz R; Véret J; Sotiropoulos A; Poirier M; Giussani P; Campana M; Philippe E; Blachnio-Zabielska A; Ballaire R; Le Liepvre X; Bourron O; Berkeš D; Górski J; Ferré P; Le Stunff H; Foufelle F; Hajduch E
Diabetes; 2018 Jul; 67(7):1258-1271. PubMed ID: 29759974
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
[TBL] [Abstract][Full Text] [Related]
32. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
33. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
Chaurasia B; Summers SA
Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
[TBL] [Abstract][Full Text] [Related]
34. Insulin Resistance, Obesity and Lipotoxicity.
Yazıcı D; Sezer H
Adv Exp Med Biol; 2017; 960():277-304. PubMed ID: 28585204
[TBL] [Abstract][Full Text] [Related]
35. The twists and turns of sphingolipid pathway in glucose regulation.
Deevska GM; Nikolova-Karakashian MN
Biochimie; 2011 Jan; 93(1):32-8. PubMed ID: 20561942
[TBL] [Abstract][Full Text] [Related]
36. Novel Insights and Mechanisms of Lipotoxicity-Driven Insulin Resistance.
Lair B; Laurens C; Van Den Bosch B; Moro C
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887221
[TBL] [Abstract][Full Text] [Related]
37. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
38. Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction.
Boslem E; Meikle PJ; Biden TJ
Islets; 2012; 4(3):177-87. PubMed ID: 22847494
[TBL] [Abstract][Full Text] [Related]
39. The role of adipose tissue and excess of fatty acids in the induction of insulin resistance in skeletal muscle.
Błachnio-Zabielska A; Grycel S; Chacińska M; Zabielski P
Postepy Hig Med Dosw (Online); 2016 Nov; 70(0):1142-1149. PubMed ID: 27892898
[TBL] [Abstract][Full Text] [Related]
40. Ceramides in Metabolism: Key Lipotoxic Players.
Chaurasia B; Summers SA
Annu Rev Physiol; 2021 Feb; 83():303-330. PubMed ID: 33158378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
